---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-22-001756"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2022-08-12T23:59:59+00:00"
generated_at: "2026-06-24T00:16:09.698431+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lexaria enters $5.925M at-the-market equity distribution agreement with Maxim Group

## Summary
- Aggregate offering price of up to $5,925,000 of common stock through Maxim Group as distribution agent.
- Sales made at market pursuant to existing S-3 registration statement (effective Feb. 4, 2022).
- Commission of 3% of gross proceeds paid to Maxim; Company also reimburses certain expenses.
- Company not obligated to sell any shares; termination on sale completion or agreement termination.
- Agreement contains customary representations, warranties, and indemnification provisions.

## SEC filing metadata
- accession: 0001640334-22-001756
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2022-08-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.0, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033422001756/0001640334-22-001756-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033422001756/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-22-001756
- JSON: https://secwatch.observer/filing/0001640334-22-001756.json
- Plain text: https://secwatch.observer/filing/0001640334-22-001756.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.